Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.63%
SPX
-0.33%
IXIC
-0.22%
FTSE
-0.38%
N225
-0.19%
AXJO
-0.11%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Alto Neuroscience News

benzinga.com

Alto Neuroscience Adds 'Intriguing' Depression Asset Via Over $100 Million Deal

Feature Image for interests on Analyst Color, Biotech, Briefs, Expert Ideas from benzinga.com
about 1 month ago
businesswire.com

Alto Neuroscience Announces Favorable Outcome from Interim Analysis of ALTO-300 Phase 2b Major Depressive Disorder Trial

Feature Image for interests on Stock, Unknown Sector from businesswire.com
5 months ago
businesswire.com

Alto Neuroscience Announces Favorable Outcome from Interim Analysis of ALTO-300 Phase 2b Major Depressive Disorder Trial

Feature Image for interests on Stock, Unknown Sector from businesswire.com
5 months ago
businesswire.com

Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology

Feature Image for interests on Stock, Unknown Sector from businesswire.com
7 months ago
businesswire.com

Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology

Feature Image for interests on Stock, Unknown Sector from businesswire.com
7 months ago
businesswire.com

Alto Neuroscience Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Feature Image for interests on Stock, Unknown Sector from businesswire.com
8 months ago
prnewswire.com

ANRO Investors Have Opportunity to Join Alto Neuroscience, Inc. Fraud Investigation with the Schall Law Firm

Feature Image for interests on Stock, The Schall Law Firm, Unknown Sector from prnewswire.com
9 months ago
businesswire.com

ANRO Investors Have Opportunity to Join Alto Neuroscience, Inc. Fraud Investigation with the Schall Law Firm

Feature Image for interests on Stock, Unknown Sector from businesswire.com
9 months ago
businesswire.com

ANRO Investors Have Opportunity to Join Alto Neuroscience, Inc. Fraud Investigation with the Schall Law Firm

Feature Image for interests on Stock, Unknown Sector from businesswire.com
9 months ago
businesswire.com

Alto Neuroscience Reports Topline Results from a Phase 2b Trial Evaluating ALTO-100 as a Treatment for Major Depressive Disorder

Feature Image for interests on Stock, Unknown Sector from businesswire.com
9 months ago

Latest Cashu News

No Cashu articles
Alto Neuroscience currently has no Cashu-related articles
Stocks
Health Care
anro
Alto Neuroscience
ANRO
+0.02 (+0.58%)
2.595
USD
At close at Jul 11, 20:47 UTC
Summary
News
Signals
Benchmarks
Financials